Arash Afsar-Zarrine
St. Michael's Hospital, 30 Bond Street
Toronto, ON M5B1W8, Canada
Toronto, ON M5B1W8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Picosecond infrared laser mass spectrometry for 10-second identification of lymphoproliferative imposter tumours in patient-derived xenografts.
Journal: Scientific reports
Published: July 30, 2025
Author Correction: Reflection mode polarimetry guides laser mass spectrometry to diagnostically important regions of human breast cancer tissue.
Journal: Scientific reports
Published: December 05, 2024
Reflection mode polarimetry guides laser mass spectrometry to diagnostically important regions of human breast cancer tissue.
Journal: Scientific reports
Published: June 03, 2024
A Workflow for Meaningful Interpretation of Classification Results from Handheld Ambient Mass Spectrometry Analysis Probes.
Journal: International journal of molecular sciences
Published: January 23, 2024
Lipid Profiling in Cancer Diagnosis with Hand-Held Ambient Mass Spectrometry Probes: Addressing the Late-Stage Performance Concerns.
Journal: Metabolites
Published: August 23, 2021
In situ tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented reality.
Journal: Chemical science
Published: June 14, 2021
Breaking Through the Barrier: Regulatory Considerations Relevant to Ambient Mass Spectrometry at the Bedside.
Journal: Clinics in laboratory medicine
Published: May 22, 2021
Potential impact of tissue molecular heterogeneity on ambient mass spectrometry profiles: a note of caution in choosing the right disease model.
Journal: Analytical and bioanalytical chemistry
Published: August 21, 2020
Platforms for rapid cancer characterization by ambient mass spectrometry: advancements, challenges and opportunities for improvement towards intrasurgical use.
Journal: The Analyst
Published: May 23, 2018
Correction: Rapid determination of the tumour stroma ratio in squamous cell carcinomas with desorption electrospray ionization mass spectrometry (DESI-MS): a proof-of-concept demonstration.
Journal: The Analyst
Published: September 02, 2017
Last Updated: 09/26/2026